These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23482058)

  • 1. The role of gut microbiota on insulin resistance.
    Caricilli AM; Saad MJ
    Nutrients; 2013 Mar; 5(3):829-51. PubMed ID: 23482058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gut microbiota on subclinical inflammation and insulin resistance.
    Carvalho BM; Saad MJ
    Mediators Inflamm; 2013; 2013():986734. PubMed ID: 23840101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus.
    Moreno-Indias I; Cardona F; Tinahones FJ; Queipo-Ortuño MI
    Front Microbiol; 2014; 5():190. PubMed ID: 24808896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota composition and its effects on obesity and insulin resistance.
    Caricilli AM; Saad MJ
    Curr Opin Clin Nutr Metab Care; 2014 Jul; 17(4):312-8. PubMed ID: 24848531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.
    Tai N; Wong FS; Wen L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):55-65. PubMed ID: 25619480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus.
    Allin KH; Nielsen T; Pedersen O
    Eur J Endocrinol; 2015 Apr; 172(4):R167-77. PubMed ID: 25416725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the role of the microbiome in obesity and type 2 diabetes.
    Hartstra AV; Bouter KE; Bäckhed F; Nieuwdorp M
    Diabetes Care; 2015 Jan; 38(1):159-65. PubMed ID: 25538312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and obesity: role in aetiology and potential therapeutic target.
    Moran CP; Shanahan F
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):585-97. PubMed ID: 25194177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.
    Napolitano A; Miller S; Nicholls AW; Baker D; Van Horn S; Thomas E; Rajpal D; Spivak A; Brown JR; Nunez DJ
    PLoS One; 2014; 9(7):e100778. PubMed ID: 24988476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.
    Chen Z; Guo L; Zhang Y; Walzem RL; Pendergast JS; Printz RL; Morris LC; Matafonova E; Stien X; Kang L; Coulon D; McGuinness OP; Niswender KD; Davies SS
    J Clin Invest; 2014 Aug; 124(8):3391-406. PubMed ID: 24960158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes.
    Sato J; Kanazawa A; Ikeda F; Yoshihara T; Goto H; Abe H; Komiya K; Kawaguchi M; Shimizu T; Ogihara T; Tamura Y; Sakurai Y; Yamamoto R; Mita T; Fujitani Y; Fukuda H; Nomoto K; Takahashi T; Asahara T; Hirose T; Nagata S; Yamashiro Y; Watada H
    Diabetes Care; 2014 Aug; 37(8):2343-50. PubMed ID: 24824547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
    Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
    Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the microbiota to address diet-induced obesity: a time dependent challenge.
    Clarke SF; Murphy EF; O'Sullivan O; Ross RP; O'Toole PW; Shanahan F; Cotter PD
    PLoS One; 2013; 8(6):e65790. PubMed ID: 23762426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance.
    Saad MJ; Santos A; Prada PO
    Physiology (Bethesda); 2016 Jul; 31(4):283-93. PubMed ID: 27252163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review.
    He FF; Li YM
    J Ovarian Res; 2020 Jun; 13(1):73. PubMed ID: 32552864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body microbiota of newborn calves and their response to prenatal vitamin and mineral supplementation.
    Luecke SM; Holman DB; Schmidt KN; Gzyl KE; Hurlbert JL; Menezes ACB; Bochantin KA; Kirsch JD; Baumgaertner F; Sedivec KK; Swanson KC; Dahlen CR; Amat S
    Front Microbiol; 2023; 14():1207601. PubMed ID: 37434710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate and obesity: Current research status and future prospect.
    Peng K; Dong W; Luo T; Tang H; Zhu W; Huang Y; Yang X
    Front Endocrinol (Lausanne); 2023; 14():1098881. PubMed ID: 36909336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and its role in obesity and insulin resistance.
    Lee CJ; Sears CL; Maruthur N
    Ann N Y Acad Sci; 2020 Feb; 1461(1):37-52. PubMed ID: 31087391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population.
    Liu F; Li P; Chen M; Luo Y; Prabhakar M; Zheng H; He Y; Qi Q; Long H; Zhang Y; Sheng H; Zhou H
    Sci Rep; 2017 Sep; 7(1):11789. PubMed ID: 28924143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and childhood malnutrition: Understanding the link and exploring therapeutic interventions.
    Zoghi S; Sadeghpour Heravi F; Nikniaz Z; Shirmohamadi M; Moaddab SY; Ebrahimzadeh Leylabadlo H
    Eng Life Sci; 2024 May; 24(5):2300070. PubMed ID: 38708416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.